Citigroup Maintains Buy on Zai Lab, Lowers Price Target to $44

Benzinga Newsdesk www.benzinga.com Negative 71.1%

Neg 71.1% Neu 0% Pos 0%

Citigroup analyst Yigal Nochomovitz maintains Zai Lab (NASDAQ:ZLAB) with a Buy and lowers the price target from $47 to $44.